In the BioHarmony Drug Report Database

"Preview" Icon

Arformoterol

Brovana (arformoterol) is a small molecule pharmaceutical. Arformoterol was first approved as Brovana on 2006-10-06. It is used to treat bronchial spasm, chronic bronchitis, and pulmonary emphysema in the USA. The pharmaceutical is active against beta-2 adrenergic receptor. In addition, it is known to target beta-1 adrenergic receptor. Brovana’s patents are valid until 2021-11-09 (FDA).

 

Trade Name

 

Brovana
 

Common Name

 

arformoterol
 

ChEMBL ID

 

CHEMBL1363
 

Indication

 

bronchial spasm, chronic bronchitis, pulmonary emphysema
 

Drug Class

 

Bronchodilators (phenethylamine derivatives)

Image (chem structure or protein)

Arformoterol structure rendering